title: Subthalamic stimulation or subthalamic lesion for Parkinson's disease? A case report.
authors.affiliation: Movement Disorder Unit, CHU de Grenoble, Grenoble Universités, France; INSERM, U836, Grenoble Institut des Neurosciences, Grenoble, France. Electronic address: mathieu.anheim@chru-strasbourg.fr.
authors.forename: Mathieu
authors.initials: M
authors.lastname: Anheim
authors.affiliation: Movement Disorder Unit, CHU de Grenoble, Grenoble Universités, France; INSERM, U836, Grenoble Institut des Neurosciences, Grenoble, France.
authors.forename: Patricia
authors.initials: P
authors.lastname: Dowsey-Limousin
authors.affiliation: Movement Disorder Unit, CHU de Grenoble, Grenoble Universités, France; INSERM, U836, Grenoble Institut des Neurosciences, Grenoble, France.
authors.forename: Paul
authors.initials: P
authors.lastname: Krack
authors.affiliation: INSERM, U836, Grenoble Institut des Neurosciences, Grenoble, France; Department of Neurosurgery, CHU de Grenoble, Grenoble Universités, France.
authors.forename: Stéphan
authors.initials: S
authors.lastname: Chabardès
authors.affiliation: INSERM, U836, Grenoble Institut des Neurosciences, Grenoble, France; Department of Neurosurgery, CHU de Grenoble, Grenoble Universités, France.
authors.forename: Alim-Louis
authors.initials: AL
authors.lastname: Benabid
authors.affiliation: Movement Disorder Unit, CHU de Grenoble, Grenoble Universités, France; INSERM, U836, Grenoble Institut des Neurosciences, Grenoble, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Pollak
mesh_terms: D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D000077465:Cabergoline; D002819:Chorea / Q000188:drug therapy / Q000209:etiology*; D003131:Combined Modality Therapy; D046690:Deep Brain Stimulation / Q000009:adverse effects* / Q000295:instrumentation; D004868:Equipment Failure; D004873:Ergolines / Q000627:therapeutic use; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D010300:Parkinson Disease / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D012008:Recurrence; D012720:Severity of Illness Index; D020531:Subthalamic Nucleus / Q000293:injuries* / Q000503:physiopathology
chemical_list: D000978:Antiparkinson Agents; D004873:Ergolines; D006220:Haloperidol; D000077465:Cabergoline
keywords: Parkinson's disease; Subthalamic nucleus chronic stimulation; Subthalamotomy